Pernille Tine Jensen

Proactive use of PROMs in ovarian cancer survivors: a systematic review

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Standard

Proactive use of PROMs in ovarian cancer survivors : a systematic review. / Kargo, Anette Stolberg; Coulter, Angela; Jensen, Pernille Tine; Steffensen, Karina Dahl.

I: Journal of Ovarian Research, Bind 12, Nr. 1, 15.07.2019, s. 63.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Harvard

Kargo, AS, Coulter, A, Jensen, PT & Steffensen, KD 2019, 'Proactive use of PROMs in ovarian cancer survivors: a systematic review', Journal of Ovarian Research, bind 12, nr. 1, s. 63. https://doi.org/10.1186/s13048-019-0538-9

APA

Kargo, A. S., Coulter, A., Jensen, P. T., & Steffensen, K. D. (2019). Proactive use of PROMs in ovarian cancer survivors: a systematic review. Journal of Ovarian Research, 12(1), 63. https://doi.org/10.1186/s13048-019-0538-9

CBE

Kargo AS, Coulter A, Jensen PT, Steffensen KD. 2019. Proactive use of PROMs in ovarian cancer survivors: a systematic review. Journal of Ovarian Research. 12(1):63. https://doi.org/10.1186/s13048-019-0538-9

MLA

Kargo, Anette Stolberg o.a.. "Proactive use of PROMs in ovarian cancer survivors: a systematic review". Journal of Ovarian Research. 2019, 12(1). 63. https://doi.org/10.1186/s13048-019-0538-9

Vancouver

Kargo AS, Coulter A, Jensen PT, Steffensen KD. Proactive use of PROMs in ovarian cancer survivors: a systematic review. Journal of Ovarian Research. 2019 jul 15;12(1):63. https://doi.org/10.1186/s13048-019-0538-9

Author

Kargo, Anette Stolberg ; Coulter, Angela ; Jensen, Pernille Tine ; Steffensen, Karina Dahl. / Proactive use of PROMs in ovarian cancer survivors : a systematic review. I: Journal of Ovarian Research. 2019 ; Bind 12, Nr. 1. s. 63.

Bibtex

@article{118081098fea41a08e9c989cbfa788a1,
title = "Proactive use of PROMs in ovarian cancer survivors: a systematic review",
abstract = "INTRODUCTION: The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to better symptom management and may prolong survival among advanced cancer patients. Ovarian cancer is a serious disease in which the majority of patients experience recurrence during the follow-up period and suffer from a number of severe symptoms from underlying disease. This systematic review was conducted to assess the evidence on the proactive use of PROMs as a dialogue tool during follow-up of ovarian cancer patients.RESULTS: The following databases were searched for relevant literature; PubMed, EMBASE, CINAHL, and the Cochrane Library. The search was conducted in April 2019 without any filters or limits. A total of 643 publications were identified, and 48 studies were found to be potentially eligible. Of the 48 papers, none met the final inclusion criterion of using PROMs proactively as a dialogue tool for ovarian cancer patients during follow-up.CONCLUSION: Studies have shown that PROMs can identify otherwise undetected symptoms. Using PROMs proactively during the consultation has been shown to improve symptom management for patients with some other types of cancer. However, we found no studies that had examined the proactive use of PROMs during follow-up of ovarian cancer patients. Future studies should evaluate if the proactive use of PROMs could facilitate a more individualized and more effective follow-up program tailored to the ovarian cancer patient's needs and preferences.",
author = "Kargo, {Anette Stolberg} and Angela Coulter and Jensen, {Pernille Tine} and Steffensen, {Karina Dahl}",
year = "2019",
month = jul,
day = "15",
doi = "10.1186/s13048-019-0538-9",
language = "English",
volume = "12",
pages = "63",
journal = "Journal of Ovarian Research",
issn = "1757-2215",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Proactive use of PROMs in ovarian cancer survivors

T2 - a systematic review

AU - Kargo, Anette Stolberg

AU - Coulter, Angela

AU - Jensen, Pernille Tine

AU - Steffensen, Karina Dahl

PY - 2019/7/15

Y1 - 2019/7/15

N2 - INTRODUCTION: The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to better symptom management and may prolong survival among advanced cancer patients. Ovarian cancer is a serious disease in which the majority of patients experience recurrence during the follow-up period and suffer from a number of severe symptoms from underlying disease. This systematic review was conducted to assess the evidence on the proactive use of PROMs as a dialogue tool during follow-up of ovarian cancer patients.RESULTS: The following databases were searched for relevant literature; PubMed, EMBASE, CINAHL, and the Cochrane Library. The search was conducted in April 2019 without any filters or limits. A total of 643 publications were identified, and 48 studies were found to be potentially eligible. Of the 48 papers, none met the final inclusion criterion of using PROMs proactively as a dialogue tool for ovarian cancer patients during follow-up.CONCLUSION: Studies have shown that PROMs can identify otherwise undetected symptoms. Using PROMs proactively during the consultation has been shown to improve symptom management for patients with some other types of cancer. However, we found no studies that had examined the proactive use of PROMs during follow-up of ovarian cancer patients. Future studies should evaluate if the proactive use of PROMs could facilitate a more individualized and more effective follow-up program tailored to the ovarian cancer patient's needs and preferences.

AB - INTRODUCTION: The use of patient reported outcome measures (PROMs) has increased during the past decade, and the focus on how to use them has resulted in a more proactive application. Studies have shown that proactive use of PROMs during treatment improves patient-clinician communication, leads to better symptom management and may prolong survival among advanced cancer patients. Ovarian cancer is a serious disease in which the majority of patients experience recurrence during the follow-up period and suffer from a number of severe symptoms from underlying disease. This systematic review was conducted to assess the evidence on the proactive use of PROMs as a dialogue tool during follow-up of ovarian cancer patients.RESULTS: The following databases were searched for relevant literature; PubMed, EMBASE, CINAHL, and the Cochrane Library. The search was conducted in April 2019 without any filters or limits. A total of 643 publications were identified, and 48 studies were found to be potentially eligible. Of the 48 papers, none met the final inclusion criterion of using PROMs proactively as a dialogue tool for ovarian cancer patients during follow-up.CONCLUSION: Studies have shown that PROMs can identify otherwise undetected symptoms. Using PROMs proactively during the consultation has been shown to improve symptom management for patients with some other types of cancer. However, we found no studies that had examined the proactive use of PROMs during follow-up of ovarian cancer patients. Future studies should evaluate if the proactive use of PROMs could facilitate a more individualized and more effective follow-up program tailored to the ovarian cancer patient's needs and preferences.

U2 - 10.1186/s13048-019-0538-9

DO - 10.1186/s13048-019-0538-9

M3 - Review

C2 - 31307510

VL - 12

SP - 63

JO - Journal of Ovarian Research

JF - Journal of Ovarian Research

SN - 1757-2215

IS - 1

ER -